The sewage crisis at the US-Mexico border continues to generate serious repercussions on public health, the environment, the ...

Mexican health authority approves Leqembi for the treatment of early Alzheimer’s disease: Tokyo Friday, December 6, 2024, 14:00 Hrs [IST] Eisai Co., Ltd. and Biogen Inc. announc ...

The Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) for the ...

Base Therapeutics has announced that its NK510 cell injection, the world's first zero-off-target base-edited NK cell product, has received IND approvals from both the U.S. FDA and China's NMPA for ...

BioArctic AB's (publ) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab) for the treatment of ...

Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced that the Federal Commission for the Protection Against Sanitary Risk ...

Eisai (ESALY) and Biogen (BIIB) announced that the Federal Commission for the Protection Against Sanitary Risk in Mexico has approved humanized ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

A federal judge has dismissed a defamation lawsuit against Fox News brought by a former Marine and Trump supporter who claimed he was made a scapegoat by the network after the Jan. 6, 2021 ...

Well, it's a huge reversal from what had been two extraordinary cases. The first federal charges against a former president. Of course there were two state-level criminal cases against Trump that ...